NCL International Logistics Public Company Limited, together with its subsidiaries, provides international freight forwarding, customs broker, inland transportation, multimodal transport operation, and other freight related services for imports and exports. The company operates through four segments: Land Transportation; Freight Forwarder; Non-Vessel Operating Common Carrier; and Producing and Distributing Dialysis. It offers logistics services for land transport, sea, and air freight forwarding services, such as full-container load, less-than-container load, and door-to-door load delivery; customs brokerage, shipper owned containers, and warehousing and domestic freight forwarding services using tractor heads and trailer trucks; and shipping agency and air freight services, as well as provides digital content support systems through telecommunication channels and operates procurement and fulfillment businesses. It also offers international sea and air freight, domestic and international transport, and other services, as well as logistics management services. In addition, the company produces and sells dialysis solution for kidney disease patients with an artificial kidney; and distributes medical supplies for use in hemodialysis. The company was formerly known as Regional First Jubilee Co., Ltd. The company was founded in 1994 and is based in Bangkok, Thailand.
Metrics to compare | NCLm | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipNCLmPeersSector | |
---|---|---|---|---|
P/E Ratio | −0.6x | 8.8x | 12.7x | |
PEG Ratio | −0.02 | −0.21 | 0.03 | |
Price/Book | 3.2x | 1.2x | 1.4x | |
Price / LTM Sales | 0.2x | 0.5x | 1.2x | |
Upside (Analyst Target) | - | 2.6% | 15.8% | |
Fair Value Upside | Unlock | 39.1% | 6.5% | Unlock |